Chemoinformaics analysis of 3,6-diacetoxy-1-hydroxy-7-methoxy-xanthen-9-one
| Molecular Weight | 358.302 | nRot | 3 |
| Heavy Atom Molecular Weight | 344.19 | nRig | 19 |
| Exact Molecular Weight | 358.069 | nRing | 3 |
| Solubility: LogS | -4.478 | nHRing | 1 |
| Solubility: LogP | 2.597 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 16 |
| nHA | 8 | APOL | 45.8111 |
| nHD | 1 | BPOL | 23.5929 |
| QED | 0.432 |
| Synth | 2.451 |
| Natural Product Likeliness | 1.021 |
| NR-PPAR-gamma | 0.794 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.485 |
| Pgp-sub | 0.005 |
| HIA | 0.321 |
| CACO-2 | -4.892 |
| MDCK | 0.0000667 |
| BBB | 0.065 |
| PPB | 0.802981 |
| VDSS | 0.827 |
| FU | 0.290933 |
| CYP1A2-inh | 0.855 |
| CYP1A2-sub | 0.7 |
| CYP2c19-inh | 0.259 |
| CYP2c19-sub | 0.073 |
| CYP2c9-inh | 0.699 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.272 |
| CYP2d6-sub | 0.295 |
| CYP3a4-inh | 0.475 |
| CYP3a4-sub | 0.182 |
| CL | 1.659 |
| T12 | 0.686 |
| hERG | 0.002 |
| Ames | 0.354 |
| ROA | 0.632 |
| SkinSen | 0.932 |
| Carcinogencity | 0.05 |
| EI | 0.864 |
| Respiratory | 0.301 |
| NR-Aromatase | 0.295 |
| Antiviral | Yes |
| Prediction | 0.839175 |